Attend a FREE Men’s Health Webinar presented by Dr. C. Mark Homra and Dr. Alberto Duboy of McIver Clinic and Coloplast to educate men and their partners about approved ED treatment options. All attendance will be confidential.
If you have ever passed a kidney stone, you probably remember that excruciating pain, and you don’t ever want to go through it again. If you have never had a stone, trust us, it is a life experience you want to skip. In either case, pay attention to these 7 ways to prevent kidney stones this summer.
You have probably seen any number of ads on the television and online about low T. They seem to indicate that this is a growing national problem and all men should begin taking medication to correct their testosterone deficiency and become more “manly men.” It might be time to slow down this growing snowball down the mountain, and look carefully to evaluate when do men need testosterone treatment? Continue reading “When Do Men Need Low Testosterone Treatment?”
PLEASANTON, CALIF. (PRWEB) JUNE 17, 2020
NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that C. Shawn West, M.D., McIver Clinic in Jacksonville, FL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. West has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.
Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.
The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.
“We are proud to name Dr. C. Shawn West as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “The UroLift System is a safe and effective treatment that allow physicians to treat men in-office under local anesthesia, so they can experience lasting symptom relief within days after receiving treatment.”
Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.
Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.
About the UroLift® System
The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.
About NeoTract | Teleflex Interventional Urology
A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose
# # #
For Teleflex Incorporated: Jake Elguicze, 610.948.2836
Treasurer and Vice President, Investor Relations
Nicole Osmer, 650.454.0504
*No instances of new, sustained erectile or ejaculatory dysfunction
1. Roehrborn, J Urology 2013 LIFT Study
2. McVary, J Sex Med 2016
MAC00968-01 Rev A
Some men shy away from talking about what’s really important. Don’t be that kind of man, especially if it concerns cancer. Instead, begin by talking with one of our physicians and asking how to do self screening for testicular cancer. Continue reading “How To Do Self Screening For Testicular Cancer”
There is certainly no shortage of stress these days, and that nagging anxiety can affect us in multiple ways, including physically. At some point in your life you will be forced to deal with it, so along with heart disease, high blood pressure, and kidney stones, here are 3 ways stress can impact urologic health.
Benign prostatic hyperplasia or BPH is what is known as an enlarged prostate. It may sound scary, but should you be concerned about an enlarged prostate? This depends on your age, whether you are symptomatic, and how severe those symptoms are. Here’s a bit more detail!
There have been speculations and opinions over the years about the value of eating vegetables and fruits to help slow the development of prostate cancer, so we’re here with new evidence that makes a clear conclusion.
BPH, or benign prostatic hyperplasia, is a condition many men deal with as they get older. An enlarged prostate gland creates multiple issues for men both during the day and at night. Before you resort to surgery, here are 7 BPH treatment options you may want to consider.
Unfortunately, many men in America share common risk factors for prostate cancer. Out of 100 American men, 13 will develop prostate cancer in their lifetime. The older a man becomes, the more his risk increases. Let’s dig deeper and discover the common causes and risk factors of prostate cancer.